Cardiogen Synthetic Peptide 100% Non-Sensitive Compliant English Description
Compliance Pre-Notice & Product Core Positioning
This product is a sequence-specific artificially synthesized Cardiogen peptide high-purity chemical intermediate produced via standardized solid-phase synthesis technology. This product is only available for formal institutional research bodies with complete academic laboratory qualifications, including university chemical research laboratories, biochemical new material research institutions, professional physical and chemical testing platforms, molecular compound screening research teams, and synthetic process development and benchmarking laboratories.
This material is strictly defined as a professional chemical synthetic laboratory reagent and industrial chemical intermediate, and shall not be classified as pharmaceutical raw material, dietary additive, daily chemical raw material or civilian formula material. Any scenarios involving human body contact, external coating, oral intake, commercial formula compounding and non-laboratory industrial processing are strictly prohibited. All purchasing institutions confirm that they possess legitimate laboratory research qualifications. Order placement means full recognition of the product’s research-only limitation, and guarantees that the material will only be used for basic indoor laboratory scientific analysis, molecular testing and synthetic comparison experiments. Unauthorized secondary repackaging, cross-domain circulation and non-laboratory application are not permitted. The supplier shall not assume joint legal responsibility for any risks and liabilities arising from unauthorized irregular use beyond laboratory research scenarios.
All content on this page focuses purely on molecular structural characteristics, physical and chemical testing parameters, industrial solid-phase synthesis technical procedures, laboratory solution preparation guidelines, sealed moisture-proof and light-shielded storage specifications, and HPLC quality control standards. The full text contains no efficacy description, no application-oriented guidance for non-laboratory scenarios, no medical-related definition and no human-body-related description. All content fully complies with cross-border e-commerce platform listing rules and international import and export customs filing standards, and can be directly used for product page release and customs declaration filing.
Basic Product Archive & Core Identification Information
Full Standard Name: Cardiogen Artificially Sequenced Synthetic Peptide, High-Purity Chemical Intermediate Exclusive for Laboratory Research
CAS Registry Number: 406-76-8
Core Preparation Technology: Industrial standardized production line based on mature SPPS solid-phase peptide synthesis process
Refining Method: Multi-gradient elution purification adopting C18 reversed-phase preparative high-performance liquid chromatography
Factory Tested Purity: HPLC main component purity ≥99.0%
Conventional Form: Uniform loose crystalline powder prepared by low-temperature vacuum freeze-drying process
Permitted Application Range Only: In-vitro molecular structural mechanism exploration, peptide synthesis route benchmarking experiments, analog impurity spectrum comparison and analysis, HPLC standard sample calibration testing, molecular structure-property relationship basic research, preliminary screening and in-vitro parameter evaluation of new synthetic compound precursors
Permanently Forbidden Application Range: Any human body administration and contact use, biological invasion testing, food and beverage ingredient compounding, daily chemical and cosmetic formula processing, prescription material preparation, clinical auxiliary testing and civilian end-product manufacturing.
R&D Background & Full Industrial Production Process
The exclusive amino acid sequence of Cardiogen peptide has completed systematic theoretical calculation, molecular structural simulation and repeated laboratory-scale synthetic verification by international fundamental biochemical research teams. Based on the mature technical framework of solid-phase peptide synthesis, after multiple rounds of technical iteration, formula debugging, parameter optimization and automated production line upgrading, a fully enclosed, intelligent and standardized mass production system has been established, realizing stable large-scale manufacturing output and consistent batch quality control.
Our factory adopts mainstream industrial SPPS solid-phase peptide synthesis technology to complete accurate targeted assembly of Cardiogen peptide molecular chains. All automated synthetic procedures are strictly implemented according to unified industrial standard parameters, including precise raw material feeding proportion, fixed peptide bond condensation cycle duration, stable system pH adjustment range and constant-temperature reaction threshold. Complete raw material incoming records, full-process operation logs and technical parameter modification files of each production batch are encrypted and permanently archived, realizing full-chain traceability and repeatable inspection covering raw material warehousing, synthetic processing, purification treatment and finished product delivery. The standardized manufacturing system effectively ensures excellent batch consistency and high experimental repeatability for academic research projects and industrial compound development experiments.
After the completion of automated peptide chain assembly, the crude synthetic material undergoes more than ten rigorous refined purification procedures in sequence, including solid-phase resin cleavage treatment, side-chain protecting group removal, crude product concentration and precipitation pretreatment, multi-stage C18 reversed-phase preparative chromatography gradient impurity elimination, anion-cation exchange resin desalting treatment, residual solvent and auxiliary agent replacement, 0.22μm microporous membrane pressure sterile filtration, and vacuum low-temperature lyophilization dehydration and shaping. The final finished product is uniform loose lyophilized crystalline powder with precisely controlled impurity components and highly stable molecular spatial folding conformation.
This high-purity synthetic peptide material is widely used in global fundamental biochemical and molecular material research fields. It is commonly applied to academic exploration of molecular metabolic characteristics of synthetic peptides, in-vitro solution system contrast testing, molecular structure-property relationship analysis, and preliminary screening and parameter evaluation of new synthetic compound molecules. It has become a standard reference experimental reagent widely stored and used in university biochemical laboratories, chemical analysis research institutions and biotechnology R&D departments worldwide.
Physical & Chemical Properties and Solubility Adaptability
The finished Cardiogen peptide product presents pure white, uniform and loose lyophilized crystalline powder with fine, smooth and evenly dispersed particles. The material possesses excellent powder fluidity without particle agglomeration, moisture-induced caking, long-term storage oxidation discoloration, foreign solid impurity particles, mildew odor or abnormal pungent chemical smell. The professional low-temperature vacuum lyophilization process completely retains the natural stable folding structure of peptide molecules, ensuring stable molecular conformation and consistent physical and chemical properties for long-term laboratory research application.
Under original factory sealed, light-shielded and low-temperature refrigerated storage conditions, the material maintains highly stable molecular structural properties, free from peptide chain hydrolysis, structural fracture and molecular performance attenuation. It supports high-precision micro-weighing, quantitative sampling, gradient stock solution preparation and low-temperature sealed preservation of split micro samples under standard laboratory environments. It effectively reduces experimental data deviation caused by uneven raw material powder properties and significantly improves the stability, credibility and repeatable verifiability of biochemical contrast experimental data.
Under standard normal temperature and normal pressure laboratory conditions, Cardiogen peptide can be completely dissolved in sterile purified deionized water and neutral PBS buffer solution. The fully dissolved solution is clear, transparent and homogeneous without suspended particles, precipitation deposition or layered turbidity. The material shows slight solubility in conventional polar organic solvents such as methanol and ethanol, and is almost insoluble in common non-polar organic solvent systems including n-hexane, petroleum ether and diethyl ether.
Working solutions prepared with pure water or standard buffer solution maintain mild and stable pH status. The dissolved system will not interfere with the inherent acid-base balance of conventional biochemical reaction systems, and will not cause structural changes to in-vitro biochemical samples. The material fully conforms to the basic technical specifications of most mainstream in-vitro biochemical and molecular laboratory experimental systems.
Each batch of finished products is tested through professional Karl Fischer moisture titration method, with internal enterprise controlled moisture content limited to ≤5.0%. Ultra-low moisture level effectively slows down the molecular hydrolysis and structural decomposition rate of peptide substances, significantly extends the valid storage cycle of sealed unopened products, reduces effective component attenuation during long-term inventory preservation, and avoids experimental data deviation and laboratory consumable waste caused by raw material performance degradation.
A 1% mass fraction aqueous solution is prepared for pH detection, showing stable weak acidity with pH value steadily maintained between 4.5 and 6.5. The material features mild chemical properties without strong corrosiveness or intense irritation, fully meeting the universal safety access standards for global conventional biochemical laboratory research materials.
Strict Quality Inspection Standards & COA Testing Items
Reversed Phase High Performance Liquid Chromatography (RP-HPLC) is adopted as the core detection method for purity verification of each batch of Cardiogen peptide raw material. Hard-copy Certificate of Analysis (COA) and electronic PDF version are attached to each batch of shipment for buyer filing and batch management. All testing items are limited to physical and chemical index detection and industrial quality control of chemically synthesized raw materials, without any biological efficacy judgment or related effect evaluation content. The detailed quality control specifications are as follows:
Main Component Purity: HPLC purity of target main component ≥99.0%. Deep purification completely removes unreacted amino acid monomers, incomplete truncated peptide fragments and synthetic side reaction byproducts to ensure high component consistency across batches and improve comparability of cross-batch experimental data.
Maximum Single Unknown Impurity: Single unknown impurity content ≤0.5% to avoid abnormal data fluctuation caused by single interfering component and guarantee accuracy of molecular comparison experiments.
Total Impurity Content: Total content of all known and unknown impurities ≤1.0%, complying with international standard for high-purity research-grade biochemical raw materials, suitable for high-precision laboratory research and compound screening experiments.
Microbial Index Control: Strict microbial index control meets the aseptic standard for in-vitro biochemical experiments, preventing microbial contamination interference to laboratory solution systems and ensuring the cleanliness and stability of experimental environments.
Qualitative Identification Confirmation: Mass spectrometry molecular weight test result is completely consistent with theoretical molecular weight; HPLC peak retention time matches official standard reference spectrum. This product can be used as qualitative standard sample for molecular identification and content calibration in peptide biochemical experiments.
Sealed Storage Specification & Shelf Life Rule
Unopened sealed drums or boxed finished products shall be stored in a constant temperature refrigerated warehouse at 2℃~8℃, kept away from humid air, direct strong light irradiation and high-temperature heat sources. The official shelf life of intact sealed original packaging is 24 months.
After opening the sealed container for sampling and stock solution preparation, the remaining solid raw material must be tightly capped and sealed immediately for refrigerated storage. The diluted liquid stock solution shall be divided into micro centrifuge tubes and stored at -20℃ away from light; repeated freeze-thaw operations are strictly prohibited. It is recommended to finish all experimental application within 1 month after subpackaging to prevent irreversible structural degradation of peptide molecules and avoid invalid experimental data.
Long-term uncovered exposure under room temperature environment is forbidden during the whole storage period. Cardiogen peptide crystalline powder has slight hygroscopicity, and open placement will easily absorb water vapor in the air to cause molecular hydrolysis and structural changes. The container must be fully sealed immediately after each sampling to isolate moisture and light, so as to maintain long-term material stability and experimental repeatability.
Pakistan
India
United States
